This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Oral bioavailability of peptides in Rybelsus and Mycapssa is around 1%.
Why it matters
Improving the oral absorption of larger molecules could lead to more effective and convenient treatments for various conditions. This is particularly important for patients who prefer oral medications over injections.
How the study worked
The article reviews recent advancements and technologies aimed at enhancing the oral absorption of middle-to-large molecules.
What this study cannot tell us
The review primarily focuses on existing drugs and does not present new experimental data or clinical trials.
Read the original research
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.
Pharmaceutics, 16(1)
Citation
Asano, Daigo; Takakusa, Hideo; Nakai, Daisuke. (2023). Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.. Pharmaceutics, 16(1). https://doi.org/10.3390/pharmaceutics16010047